Evidence map›Paper›PMID 24986113›Full record

Trial reportJournal of oncology practice2014

When using patient-reported outcomes in clinical practice, the measure matters: a randomized controlled trial.

Claire F Snyder, Joseph M Herman, Sharon M White, Brandon S Luber, Amanda L Blackford, Michael A Carducci, Albert W Wu

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Journal of oncology practice, 2014. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 40 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
40citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

40 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Improving an electronic system for measuring PROs in routine oncology practice.Journal of cancer survivorship : research and practice · 2016
    Trial
  5. Article
  6. Review
  7. Article
  8. Review
  9. Article
  10. PROMIS-29 and EORTC QLQ-C30: an empirical investigation towards a common conception of health.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2023
    Article
  11. A PRO-cision medicine intervention to personalize cancer care using patient-reported outcomes: intervention development and feasibility-testing.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2022
    Article
  12. Article
  13. Article
  14. Optimal assessment of quality of life for patients with prostate cancer.Therapeutic advances in medical oncology · 2022
    Review
  15. Patient-reported experience with patient-reported outcome measures in adult patients seen in rheumatology clinics.Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation · 2021
    Article
  16. Feasibility of implementing a cervix cancer-specific patient-reported outcome measure in routine ambulatory clinics.Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer · 2021
    Article
  17. Review
  18. Article
  19. Integration of Patient-reported Outcomes in a Total Joint Arthroplasty Program at a High-volume Academic Medical Center.Journal of the American Academy of Orthopaedic Surgeons. Global research & reviews · 2020
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Claire F SnyderJohns Hopkins School of Medicine; Johns Hopkins Bloomberg School of Public Health; and Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD csnyder@jhsph.edu.
Joseph M HermanJohns Hopkins School of Medicine; Johns Hopkins Bloomberg School of Public Health; and Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD.
Sharon M WhiteJohns Hopkins School of Medicine; Johns Hopkins Bloomberg School of Public Health; and Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD.
Brandon S LuberJohns Hopkins School of Medicine; Johns Hopkins Bloomberg School of Public Health; and Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD.
Amanda L BlackfordJohns Hopkins School of Medicine; Johns Hopkins Bloomberg School of Public Health; and Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD.
Michael A CarducciJohns Hopkins School of Medicine; Johns Hopkins Bloomberg School of Public Health; and Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD.
Albert W WuJohns Hopkins School of Medicine; Johns Hopkins Bloomberg School of Public Health; and Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins, Baltimore, MD.

Funding

Translational Research Central ServicesP30CA006973 · NCI · JOHNS HOPKINS UNIVERSITY · PI Rosalie Wollett · 1985 to 2026
$208.6M
Feasibility and Value of a Website for Assessing Patient-Reported OutcomesR21CA134805 · NCI · JOHNS HOPKINS UNIVERSITY · PI SNYDER, CLAIRE F, WU, ALBERT W. · 2009 to 2010
$397k
A Website for Outpatient Quality of Life AssessmentR21CA113223 · NCI · JOHNS HOPKINS UNIVERSITY · PI WU, ALBERT W. · 2005 to 2006
$208k
NCI NIH HHS 1R21CA113223-01NCI NIH HHS 1R21CA134805-01A1NCI NIH HHS P30 CA006973NCI NIH HHS R21 CA113223NCI NIH HHS R21 CA134805
6 · The paper itself

Abstract

backgroundPatient-reported outcome (PRO) measures are increasingly being used in clinical practice to inform individual patient management, but evidence is needed on which PROs are best suited for clinical use.

methodsThis controlled trial randomly assigned patients with breast and prostate cancer undergoing treatment to complete one of three PRO measures: European Organisation for Research and Treatment of Cancer Quality of Life Questionnaire-Core 30 (QLQ-C30), Supportive Care Needs Survey-Short Form (SCNS-SF34), or six domains from the Patient-Reported Outcomes Measurement Information System (PROMIS). Patients completed the PRO measures before clinic visits, and the results were provided to both the patient and clinician. At treatment completion, patients and clinicians completed brief feedback forms on the intervention's usefulness and value. Exit interviews were conducted with patients (at end of treatment) and clinicians (at end of study). The primary outcome was the proportion of patients in each arm who either strongly agreed or agreed to all feedback form items.

resultsOf 294 eligible patients invited to participate, 224 (76%) enrolled (median age 66 years, 78% white, 72% prostate). Of the 181 patients (81%) who completed at least one feedback form item, participants in the QLQ-C30 study arm were most likely to strongly agree/agree to all items (74%) followed by PROMIS (61%) and SCNS-SF34 (52%; P = .03). Of the 116 participants (52%) who completed all feedback form items, the results were similar: 82% for the QLQ-C30, 62% for PROMIS, and 56% for SCNS-SF34 (P = .05). Clinicians did not prefer one questionnaire over the others.

conclusionThese results suggest that, when using PROs in clinical practice for patient management, the measure matters in terms of usefulness to patients.

Indexed as

Self ReportAdultAgedAged, 80 and overAlgorithmsBreast NeoplasmsFemaleHumansMaleMedical OncologyMiddle AgedPatient PreferencePatient SatisfactionProstatic NeoplasmsQuality of LifeResearch Design

Identifiers

PMID24986113
PMCPMC4161731

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.